INFINANT HEALTH Trademark

Trademark Overview


On Friday, August 19, 2022, a trademark application was filed for INFINANT HEALTH with the United States Patent and Trademark Office. The USPTO has given the INFINANT HEALTH trademark a serial number of 97555625. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, September 5, 2024. This trademark is owned by Evolve BioSystems Inc.. The INFINANT HEALTH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Developing microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; research and development of products for the diagnosis of human disease or human health-related conditions; research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; medical and scientific research in the field(s) of infant gut microbiome health, maternal-inf...
infinant health

General Information


Serial Number97555625
Word MarkINFINANT HEALTH
Filing DateFriday, August 19, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, September 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 17, 2023

Trademark Statements


NOT AVAILABLE"HEALTH"
Goods and ServicesDeveloping microbiome preparations for foods and medicines for use by mother and infant pairs; developing microbiome preparations for use in treating patients with atopic, allergic, inflammation, inflammatory conditions, infections, autoimmune, cognitive, metabolic disorders and diseases; development of microbiome preparations for pregnant women; development of microbiome preparations for the prevention and treatment of autism; development of microbiome preparations for older adults, elderly; pharmaceutical and non-pharmaceutical product research and development; product research and development of medicines, nutritional and dietary supplements; research and development of products for the diagnosis of human disease or human health-related conditions; research of non-pharmaceutical and pharmaceutical products for the prevention or treatment of human diseases or human health-related conditions; medical and scientific research in the field(s) of infant gut microbiome health, maternal-infant health and wellness, infant health and wellness, preterm infant health and wellness; research and development in the field(s) of maternal health, infant health, preterm infant health, gut health, immune health, namely, vaccine efficiency, and metabolic health; biomedical research services related to health and clinical status of pregnant women, preterm infants, term infants, toddlers and children; research and development of diagnostics for biological, behavioral, auditory, and pictorial health indicators; medical and bioscience research services in the areas of the microbiome, immune system, metabolic systems of pregnant women, preterm infants, term infants, toddlers and children; medical and bioscience research services in to the areas of the microbiome, immune system, and metabolic systems of older adults and elderly

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 8, 2022
Primary Code042
First Use Anywhere DateMonday, October 3, 2022
First Use In Commerce DateMonday, October 3, 2022

Trademark Owner History


Party NameINFINANT HEALTH, INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDavis, CA 95618

Party NameINFINANT HEALTH, INC
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressDavis, CA 95618

Party NameEvolve BioSystems Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDavis, CA 95618

Trademark Events


Event DateEvent Description
Friday, February 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 23, 2022NEW APPLICATION ENTERED
Thursday, September 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 7, 2023ASSIGNED TO EXAMINER
Thursday, June 8, 2023NON-FINAL ACTION WRITTEN
Thursday, June 8, 2023NON-FINAL ACTION E-MAILED
Thursday, June 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 6, 2024TEAS STATEMENT OF USE RECEIVED
Friday, July 19, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 6, 2024USE AMENDMENT FILED
Friday, July 19, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 5, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, September 5, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED